Display options
Share it on

Front Physiol. 2017 Jun 13;8:379. doi: 10.3389/fphys.2017.00379. eCollection 2017.

Human Peritoneal Mesothelial Cell Death Induced by High-Glucose Hypertonic Solution Involves Ca.

Frontiers in physiology

Felipe Simon, Pablo Tapia, Ricardo Armisen, Cesar Echeverria, Sebastian Gatica, Alejandro Vallejos, Alejandro Pacheco, Maria E Sanhueza, Miriam Alvo, Erico Segovia, Rubén Torres

Affiliations

  1. Departamento de Ciencias Biologicas, Facultad de Ciencias Biologicas and Facultad de Medicina, Universidad Andres BelloSantiago, Chile.
  2. Millennium Institute on Immunology and ImmunotherapySantiago, Chile.
  3. Unidad de Paciente Critico, Hospital Clínico Metropolitano de La FloridaSantiago, Chile.
  4. Centro de Investigación y Tratamiento del Cancer, Facultad de Medicina, Universidad de ChileSantiago, Chile.
  5. Center for Excellence in Precision Medicine Pfizer, Pfizer ChileSantiago, Chile.
  6. Centro Integrativo de Biología y Química Aplicada, Universidad Bernardo OHigginsSantiago, Chile.
  7. Sección de Nefrología, Departamento de Medicina, Hospital Clínico Universidad de ChileSantiago, Chile.
  8. Facultad de Medicina, Instituto de Ciencias Biomédicas, Universidad de ChileSantiago, Chile.

PMID: 28659813 PMCID: PMC5468383 DOI: 10.3389/fphys.2017.00379

Abstract

Chronic peritoneal dialysis (PD) therapy is equally efficient as hemodialysis while providing greater patient comfort and mobility. Therefore, PD is the treatment of choice for several types of renal patients. During PD, a high-glucose hyperosmotic (HGH) solution is administered into the peritoneal cavity to generate an osmotic gradient that promotes water and solutes transport from peritoneal blood to the dialysis solution. Unfortunately, PD has been associated with a loss of peritoneal viability and function through the generation of a severe inflammatory state that induces human peritoneal mesothelial cell (HPMC) death. Despite this deleterious effect, the precise molecular mechanism of HPMC death as induced by HGH solutions is far from being understood. Therefore, the aim of this study was to explore the pathways involved in HGH solution-induced HPMC death. HGH-induced HPMC death included influxes of intracellular Ca

Keywords: cell death; dialysis; hypertonicity; mesothelial cell; peritoneal tissue

References

  1. Biochemistry. 1997 Jun 17;36(24):7474-80 - PubMed
  2. Infect Immun. 2014 Sep;82(9):3678-86 - PubMed
  3. Int J Mol Med. 2011 Feb;27(2):187-93 - PubMed
  4. Inflamm Res. 2012 Oct;61(10):1107-16 - PubMed
  5. Antioxid Redox Signal. 2011 Nov 1;15(9):2425-38 - PubMed
  6. Cardiovasc Res. 2011 Nov 1;92(2):237-46 - PubMed
  7. Oxid Med Cell Longev. 2014;2014:642793 - PubMed
  8. Am J Physiol Cell Physiol. 2011 Jan;300(1):C6-8 - PubMed
  9. J Cell Biochem. 2012 Oct;113(10 ):3288-98 - PubMed
  10. Kidney Int Suppl. 2008 Apr;(108):S26-33 - PubMed
  11. J Am Soc Nephrol. 2006 Jan;17(1):199-207 - PubMed
  12. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Apr;35(4):295-300 - PubMed
  13. J Biol Chem. 1994 Sep 23;269(38):23431-6 - PubMed
  14. J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S221-6 - PubMed
  15. J Am Soc Nephrol. 2002 May;13(5):1321-30 - PubMed
  16. Kidney Int. 2004 Sep;66(3):1257-65 - PubMed
  17. J Biol Chem. 1999 May 28;274(22):15533-7 - PubMed
  18. Curr Mol Med. 2008 May;8(3):187-206 - PubMed
  19. Nephrol Dial Transplant. 2004 Sep;19(9):2208-16 - PubMed
  20. Perit Dial Int. 2013 Mar-Apr;33(2):143-54 - PubMed
  21. Kidney Int. 2004 Apr;65(4):1170-9 - PubMed
  22. Cytokine Growth Factor Rev. 2017 Feb;33:41-54 - PubMed
  23. J Hypertens. 2009 Jun;27(6):1202-16 - PubMed
  24. Free Radic Biol Med. 2003 Dec 1;35(11):1457-68 - PubMed
  25. Am J Physiol Cell Physiol. 2011 Jan;300(1):C14-21 - PubMed
  26. Nat Rev Cancer. 2006 May;6(5):392-401 - PubMed
  27. Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5130-5 - PubMed
  28. Lab Invest. 2014 Oct;94(10):1068-82 - PubMed
  29. Am J Physiol Heart Circ Physiol. 2002 May;282(5):H1855-62 - PubMed
  30. PLoS One. 2011;6(8):e23116 - PubMed
  31. Biophys J. 2006 May 15;90(10):3546-54 - PubMed
  32. Thromb Haemost. 2009 Apr;101(4):619-25 - PubMed
  33. J Biol Chem. 2010 Nov 26;285(48):37150-8 - PubMed
  34. Perit Dial Int. 1992;12(2):252-6 - PubMed
  35. Histochem Cell Biol. 2011 Feb;135(2):173-81 - PubMed
  36. Perit Dial Int. 2000;20 Suppl 5:S10-8 - PubMed
  37. Life Sci. 2012 Apr 9;90(13-14):509-18 - PubMed
  38. Perit Dial Int. 2009 Feb;29 Suppl 2:S123-7 - PubMed
  39. Diabetes. 2003 May;52(5):1256-64 - PubMed
  40. Lab Invest. 2007 Apr;87(4):345-56 - PubMed
  41. Clin Nephrol. 2015 Jan;83(1):1-10 - PubMed
  42. Clin Exp Nephrol. 2016 Feb;20(1):30-8 - PubMed
  43. Am J Nephrol. 2010;31(1):58-67 - PubMed
  44. Purinergic Signal. 2012 Sep;8(3):539-57 - PubMed
  45. J Am Soc Nephrol. 2005 Mar;16(3):667-75 - PubMed
  46. Curr Opin Immunol. 2004 Feb;16(1):42-7 - PubMed
  47. Endothelium. 2008 Jul-Aug;15(4):175-88 - PubMed
  48. Antioxid Redox Signal. 2002 Feb;4(1):35-8 - PubMed
  49. J Immunol. 2003 May 15;170(10):5302-8 - PubMed
  50. Transplant Proc. 2003 Aug;35(5):1931-2 - PubMed
  51. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016 May 25;45(6):598-606 - PubMed
  52. Purinergic Signal. 2016 Sep;12(3):497-507 - PubMed
  53. Antioxid Redox Signal. 2011 May 15;14(10):1815-27 - PubMed
  54. Biochim Biophys Acta. 2013 Mar;1828(3):1169-79 - PubMed
  55. Perit Dial Int. 2009 Mar-Apr;29(2):227-30 - PubMed
  56. Cell Signal. 2014 Mar;26(3):528-39 - PubMed
  57. Contrib Nephrol. 2006;150:84-9 - PubMed
  58. Nephron Exp Nephrol. 2006;103(4):e166-74 - PubMed
  59. J Am Soc Nephrol. 2001 May;12(5):1046-51 - PubMed
  60. J Am Soc Nephrol. 2002 Feb;13(2):470-9 - PubMed
  61. Acta Pharmacol Sin. 2013 Apr;34(4):507-14 - PubMed
  62. Cardiovasc Res. 2011 Sep 1;91(4):677-84 - PubMed
  63. Perit Dial Int. 2002 Jan-Feb;22(1):11-21 - PubMed
  64. Nat Rev Nephrol. 2013 Jul;9(7):419-29 - PubMed
  65. Front Cell Neurosci. 2015 Jul 27;9:267 - PubMed
  66. Perit Dial Int. 2000;20 Suppl 2:S31-6 - PubMed
  67. J Clin Invest. 2003 Dec;112(12):1776-84 - PubMed
  68. Nephrol Dial Transplant. 2003 Jun;18(6):1086-94 - PubMed
  69. Physiol Rev. 2002 Jan;82(1):47-95 - PubMed
  70. Pharmacol Ther. 2017 Feb;170:148-165 - PubMed
  71. Perit Dial Int. 2000;20 Suppl 2:S15-8 - PubMed
  72. Biochemistry. 1999 May 4;38(18):5746-53 - PubMed
  73. Kidney Int. 1998 May;53(5):1278-87 - PubMed
  74. Nephrol Dial Transplant. 2009 Mar;24(3):809-15 - PubMed
  75. J Cell Biochem. 2013 Nov;114(11):2595-602 - PubMed
  76. BMC Cell Biol. 2016 May 24;17 Suppl 1:17 - PubMed
  77. J Interferon Cytokine Res. 2016 Jan;36(1):48-61 - PubMed
  78. Free Radic Biol Med. 2007 Mar 1;42(5):636-41 - PubMed
  79. FASEB J. 2004 Jul;18(10):1126-8 - PubMed
  80. J Cell Physiol. 2015 Aug;230(8):1916-28 - PubMed
  81. Semin Dial. 2008 May-Jun;21(3):258-65 - PubMed
  82. Cell Physiol Biochem. 2015 ;35(3):1008-22 - PubMed
  83. N Engl J Med. 2003 Jan 30;348(5):403-13 - PubMed
  84. Nat Rev Nephrol. 2012 Feb 21;8(4):224-33 - PubMed
  85. PLoS One. 2014 Apr 07;9(4):e94146 - PubMed
  86. J Am Soc Nephrol. 2007 Jul;18(7):2004-13 - PubMed
  87. J Biol Chem. 2004 Apr 2;279(14):13301-4 - PubMed
  88. Kidney Int. 1999 Jan;55(1):341-56 - PubMed

Publication Types